Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 11 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

9%

1 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 4
1(20.0%)
5Total
N/A(4)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials
NCT06518213Completed

Efficacy and Safety of First-line ART With BIC/FTC/TAF Introduced at the First Clinical Visit

Role: lead

NCT06021743Unknown

The Role of Immune Semaphorins in Steatotic Liver Disease and Sepsis

Role: lead

NCT04573543Completed

The Role of Immune Semaphorins in NAFLD

Role: lead

NCT04982328Completed

COVID-19 and Nonalcoholic Fatty Liver Disease

Role: lead

NCT04725669Not ApplicableUnknown

Seroprevalence of Pertussis Among Children and Adolescents in Croatia

Role: lead

NCT04359667Unknown

Serum IL-6 and Soluble IL-6 Receptor in Severe COVID-19 Pneumonia Treated With Tocilizumab

Role: lead

NCT04116307Phase 4Completed

Enteroadsorbent Polymethylsiloxane vs Probiotic Lactobacillus Reuteri in the Treatment of Rotaviral Gastroenteritis

Role: lead

NCT02704013Not ApplicableUnknown

Urinary Biomarkers in Overactive Bladder in Children

Role: collaborator

NCT01385436Unknown

Distribution of Human Papillomavirus (HPV) Genotypes in Patients With Cervical Cancer From Croatia

Role: lead

NCT00925795Not ApplicableCompleted

Effect of Extra Virgin Olive Oil on Atherosclerosis Biomarkers in HIV-infected Patients

Role: lead

NCT01156740Not ApplicableCompleted

Treatment of Group A Beta Hemolytic Streptococcal Pharyngitis in Children in Low Resource Settings

Role: collaborator

All 11 trials loaded